ZEPP
LIVE

Serial Number

99024523

Owner

CSL Behring LLC

Attorney

Scott Woldow

Filing Date

Jan 31, 2025

Add to watchlist:

No watchlists yet
View on USPTO

ZEPP Trademark

Serial Number: 99024523

ZEPP is a trademark filed by CSL Behring LLC on January 31, 2025. The trademark is classified under Class 40 (Treatment & Processing), Class 42 (Computer & Scientific), Class 45 (Legal & Security Services), Class 35 (Advertising & Business). The application is currently pending registration.

Owner Contact Info

CSL Behring LLC (13 trademarks)

1020 First Avenue
King of Prussia, PA 194060901

Entity Type: 16

Trademark Details

Filing Date

January 31, 2025

Registration Date

Not Registered

Goods & Services

Regulatory compliance consulting in the field of biotechnology; Regulatory compliance consulting in the field of pharmaceuticals; Providing Information about legal eligibility requirements for government medical and pharmaceutical programs; Regulatory and legal process pathway consulting for clinical manufacturing.

Electronic data collection and data submission services for business purposes in the fields of medicine, healthcare and related research; Providing an on-line database providing business intelligence in the fields of medical devices, pharmaceuticals and life sciences; Providing business intelligence services in the fields of pharmaceuticals and the life sciences.

Scientific, pharmaceutical and medical research and development; biological research; Platform as a Service {PAAS} services featuring software for scientific research, pharmaceutical research, and medical research for reviewing, organizing and displaying research information in the field of bioproduction and regulatory pathway services; Research on the subject of pharmaceuticals; Pharmaceutical drug development services; Pharmaceutical research and development; Pharmaceutical products development; Providing medical research information in the field of pharmaceuticals; Providing scientific research information in the field of pharmaceuticals; Conducting early evaluations in the field of new pharmaceuticals; pharmaceutical product evaluation; Research and development services relating to pharmaceuticals and medicines; development of pharmaceutical preparations and medicines; Providing medical and scientific research information in the fields of pharmaceuticals; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Consulting services in the field of pharmaceutical and medicinal research; Consulting services in the field of pharmaceutical research and development; Consulting services in the field of biotechnology; Consulting services in the field of pharmaceuticals, biopharmaceuticals, and fractionation.

Biomanufacturing for others, namely, manufacturing of pharmaceuticals; custom biomanufacturing of biological preparations; Custom manufacture of pharmaceuticals; Custom manufacturing services, namely, fractionation services for others.

Filing History

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Feb 3, 2026 GNS3
LETTER OF SUSPENSION E-MAILED
Feb 3, 2026 GNSL
SUSPENSION LETTER WRITTEN
Feb 3, 2026 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 12, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 12, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 12, 2026 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Oct 13, 2025 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Oct 13, 2025 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 11, 2025 GNRN
NON-FINAL ACTION E-MAILED
Jul 11, 2025 GNRT
NON-FINAL ACTION WRITTEN
Jul 11, 2025 CNRT
ASSIGNED TO EXAMINER
Jul 11, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 2, 2025 NWOS
APPLICATION FILING RECEIPT MAILED
Jan 31, 2025 MAFR
NEW APPLICATION ENTERED
Jan 31, 2025 NWAP